285 high-priced antihypertensive drugs to be delisted from health insurance
Published: 2010-09-17 06:57:00
Updated: 2010-09-17 06:57:00
The Health Insurance Review Assessment and Service said on September 15 it will exclude a total of 285 antihypertensive agents from health insurance coverage within this year, since they are deemed to less cost-effective items and in the 80-percent pricing level over original drugs.
The drug a...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
